149 related articles for article (PubMed ID: 12758065)
1. Molecular investigation of TBP allele length: a SCA17 cellular model and population study.
Reid SJ; Rees MI; van Roon-Mom WM; Jones AL; MacDonald ME; Sutherland G; During MJ; Faull RL; Owen MJ; Dragunow M; Snell RG
Neurobiol Dis; 2003 Jun; 13(1):37-45. PubMed ID: 12758065
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional dysregulation of TrkA associates with neurodegeneration in spinocerebellar ataxia type 17.
Shah AG; Friedman MJ; Huang S; Roberts M; Li XJ; Li S
Hum Mol Genet; 2009 Nov; 18(21):4141-52. PubMed ID: 19643914
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanisms and Therapeutics for SCA17.
Liu Q; Pan Y; Li XJ; Li S
Neurotherapeutics; 2019 Oct; 16(4):1097-1105. PubMed ID: 31317427
[TBL] [Abstract][Full Text] [Related]
4. HAP1 can sequester a subset of TBP in cytoplasmic inclusions via specific interaction with the conserved TBP(CORE).
Prigge JR; Schmidt EE
BMC Mol Biol; 2007 Sep; 8():76. PubMed ID: 17868456
[TBL] [Abstract][Full Text] [Related]
5. Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17.
Yang Y; Yang S; Guo J; Cui Y; Tang B; Li XJ; Li S
J Neurosci; 2017 Sep; 37(38):9101-9115. PubMed ID: 28821675
[TBL] [Abstract][Full Text] [Related]
6. Polyglutamine expansion reduces the association of TATA-binding protein with DNA and induces DNA binding-independent neurotoxicity.
Friedman MJ; Wang CE; Li XJ; Li S
J Biol Chem; 2008 Mar; 283(13):8283-90. PubMed ID: 18218637
[TBL] [Abstract][Full Text] [Related]
7. Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17.
Oda M; Maruyama H; Komure O; Morino H; Terasawa H; Izumi Y; Imamura T; Yasuda M; Ichikawa K; Ogawa M; Matsumoto M; Kawakami H
Arch Neurol; 2004 Feb; 61(2):209-12. PubMed ID: 14967767
[TBL] [Abstract][Full Text] [Related]
8. TBP, a polyglutamine tract containing protein, accumulates in Alzheimer's disease.
Reid SJ; van Roon-Mom WM; Wood PC; Rees MI; Owen MJ; Faull RL; Dragunow M; Snell RG
Brain Res Mol Brain Res; 2004 Jun; 125(1-2):120-8. PubMed ID: 15193429
[TBL] [Abstract][Full Text] [Related]
9. Large Polyglutamine Repeats Cause Muscle Degeneration in SCA17 Mice.
Huang S; Yang S; Guo J; Yan S; Gaertig MA; Li S; Li XJ
Cell Rep; 2015 Oct; 13(1):196-208. PubMed ID: 26387956
[TBL] [Abstract][Full Text] [Related]
10. Deactivation of TBP contributes to SCA17 pathogenesis.
Hsu TC; Wang CK; Yang CY; Lee LC; Hsieh-Li HM; Ro LS; Chen CM; Lee-Chen GJ; Su MT
Hum Mol Genet; 2014 Dec; 23(25):6878-93. PubMed ID: 25104854
[TBL] [Abstract][Full Text] [Related]
11. Spinocerebellar Ataxia Type 17 (SCA17).
Toyoshima Y; Takahashi H
Adv Exp Med Biol; 2018; 1049():219-231. PubMed ID: 29427105
[TBL] [Abstract][Full Text] [Related]
12. Spinocerebellar ataxia type 17: report of a family with reduced penetrance of an unstable Gln49 TBP allele, haplotype analysis supporting a founder effect for unstable alleles and comparative analysis of SCA17 genotypes.
Zühlke C; Dalski A; Schwinger E; Finckh U
BMC Med Genet; 2005 Jul; 6():27. PubMed ID: 15989694
[TBL] [Abstract][Full Text] [Related]
13. Cerebellum-enriched protein INPP5A contributes to selective neuropathology in mouse model of spinocerebellar ataxias type 17.
Liu Q; Huang S; Yin P; Yang S; Zhang J; Jing L; Cheng S; Tang B; Li XJ; Pan Y; Li S
Nat Commun; 2020 Feb; 11(1):1101. PubMed ID: 32107387
[TBL] [Abstract][Full Text] [Related]
14. Small-expanded allele spinocerebellar ataxia 17: imaging and phenotypic variability.
Paolini Paoletti F; Prontera P; Nigro P; Simoni S; Cappelletti G; Filidei M; Calabresi P; Parnetti L; Tambasco N
Neurol Sci; 2021 Oct; 42(10):4309-4315. PubMed ID: 34031796
[TBL] [Abstract][Full Text] [Related]
15. A novel transgenic rat model for spinocerebellar ataxia type 17 recapitulates neuropathological changes and supplies in vivo imaging biomarkers.
Kelp A; Koeppen AH; Petrasch-Parwez E; Calaminus C; Bauer C; Portal E; Yu-Taeger L; Pichler B; Bauer P; Riess O; Nguyen HP
J Neurosci; 2013 May; 33(21):9068-81. PubMed ID: 23699518
[TBL] [Abstract][Full Text] [Related]
16. Digenic inheritance of STUB1 variants and TBP polyglutamine expansions explains the incomplete penetrance of SCA17 and SCA48.
Magri S; Nanetti L; Gellera C; Sarto E; Rizzo E; Mongelli A; Ricci B; Fancellu R; Sambati L; Cortelli P; Brusco A; Bruzzone MG; Mariotti C; Di Bella D; Taroni F
Genet Med; 2022 Jan; 24(1):29-40. PubMed ID: 34906452
[TBL] [Abstract][Full Text] [Related]
17. Genetically modified rodent models of SCA17.
Cui Y; Yang S; Li XJ; Li S
J Neurosci Res; 2017 Aug; 95(8):1540-1547. PubMed ID: 27859490
[TBL] [Abstract][Full Text] [Related]
18. [Advance in research on spinocerebellar ataxia 17].
Zhang J; Gu W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Feb; 31(1):44-7. PubMed ID: 24510561
[TBL] [Abstract][Full Text] [Related]
19. Mutation analysis of the TATA box-binding protein (TBP) gene in Chinese Han patients with spinocerebellar ataxia.
Xu Q; Li XH; Wang JL; Jiang H; Zhang S; Lei LF; Shen L; Xia K; Pan Q; Long ZG; Tang BS
J Clin Neurosci; 2009 Oct; 16(10):1374-5. PubMed ID: 19581089
[TBL] [Abstract][Full Text] [Related]
20. Complex Ataxia-Dementia Phenotype in Patients with Digenic TBP/STUB1 Spinocerebellar Ataxia.
Nanetti L; Magri S; Fichera M; Castaldo A; Nigri A; Pinardi C; Mongelli A; Sarro L; Pareyson D; Grisoli M; Gellera C; Di Bella D; Mariotti C; Taroni F
Mov Disord; 2023 Apr; 38(4):665-675. PubMed ID: 36799493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]